A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Southern District of Texas ...

The Biden administration’s drug-price negotiation law threatens new product development and will lead to fewer new medicines ...

Kaleb Johnson uses his speed to outrun the Minnesota defense and score a 40-yard touchdown in the third quarter, giving Iowa ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for Lupus Nephritis. According to GlobalData, Phase II drugs for Lupus Nephritis have a 50% phase transition ...

Johnson & Johnson (JNJ) closed the most recent trading day at $166.61, moving +1.36% from the previous trading session. This move outpaced the S&P 500's daily gain of 1.16%. At the same time, the Dow ...

Iowa RB Kaleb Johnson recorded a career-high 206 yards and three touchdowns to help lead Iowa to a 31-14 victory over ...

Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, is showcasing its industry ...